Home/Filings/4/0000950170-24-059850
4//SEC Filing

REEVE GRAHAM D. 4

Accession 0000950170-24-059850

CIK 0000885978other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 6:15 PM ET

Size

6.4 KB

Accession

0000950170-24-059850

Insider Transaction Report

Form 4
Period: 2024-05-10
Transactions
  • Sale

    Common Stock

    2024-05-10$105.46/sh1,724$181,8136,970 total(indirect: By Trust)
Holdings
  • Common Stock

    16,468
Footnotes (2)
  • [F1]The price reported ($105.46) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $105.44 to $105.50 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F2]Includes 16,468 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,792 shares on July 1, 2024, and October 1, 2024; 1,793 shares on January 1, 2025, 1,442 shares on April 1, 2025, July 1, 2025, October 1, 2025; 1,459 shares on January 1, 2026; 818 shares on April 1, 2026, July 1, 2026, October 1, 2026; 827 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027 and 507 shares on Janaury 2028, if he is a director of the Company on those dates.

Documents

1 file

Issuer

U S PHYSICAL THERAPY INC /NV

CIK 0000885978

Entity typeother

Related Parties

1
  • filerCIK 0001519948

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 6:15 PM ET
Size
6.4 KB